Sales by Covidien’s medical devices division outpaced other segments of the company in the fourth quarter of fiscal 2009, growing 7% to reach $1.6bn. Significantly higher sales of stapling products fuelled the double-digit growth in endomechanical products sales, the company ...
Please Login to read the full article.
